Palmedo H - Search Results

1

Reactor-produced radioisotopes from ORNL for bone pain palliation.

Knapp FF Jr, Mirzadeh S, Beets AL, O'Doherty M, Blower PJ, Verdera ES, Gaudiano JS, Kropp J, Guhlke J, Palmedo H, Biersack HJ. Knapp FF Jr, et al. Among authors: palmedo h. Appl Radiat Isot. 1998 Apr;49(4):309-15. doi: 10.1016/s0969-8043(97)00043-2. Appl Radiat Isot. 1998. PMID: 9519440

2

Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.

Knapp FF Jr, Beets AL, Guhlke S, Zamora PO, Bender H, Palmedo H, Biersack HJ. Knapp FF Jr, et al. Among authors: palmedo h. Anticancer Res. 1997 May-Jun;17(3B):1783-95. Anticancer Res. 1997. PMID: 9179235

3

Palliation and survival after repeated (188)Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: a retrospective analysis.

Biersack HJ, Palmedo H, Andris A, Rogenhofer S, Knapp FF, Guhlke S, Ezziddin S, Bucerius J, von Mallek D. Biersack HJ, et al. Among authors: palmedo h. J Nucl Med. 2011 Nov;52(11):1721-6. doi: 10.2967/jnumed.111.093674. Epub 2011 Oct 5. J Nucl Med. 2011. PMID: 21976530 Free article.

4

Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.

Palmedo H, Grünwald F, Wagner U, Köhler S, Krebs D, Biersack HJ. Palmedo H, et al. Clin Nucl Med. 1998 Aug;23(8):501-4. doi: 10.1097/00003072-199808000-00001. Clin Nucl Med. 1998. PMID: 9712380

5

Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.

Palmedo H, Bender H, Dierke-Dzierzon C, Carl UM, Risse J, Krebs D, Biersack HJ. Palmedo H, et al. Clin Nucl Med. 1999 Sep;24(9):643-8. doi: 10.1097/00003072-199909000-00001. Clin Nucl Med. 1999. PMID: 10478737

6

Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.

Palmedo H, Guhlke S, Bender H, Sartor J, Schoeneich G, Risse J, Grünwald F, Knapp FF Jr, Biersack HJ. Palmedo H, et al. Eur J Nucl Med. 2000 Feb;27(2):123-30. doi: 10.1007/s002590050017. Eur J Nucl Med. 2000. PMID: 10755716 Clinical Trial.

7

Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.

Palmedo H, Manka-Waluch A, Albers P, Schmidt-Wolf IG, Reinhardt M, Ezziddin S, Joe A, Roedel R, Fimmers R, Knapp FF Jr, Guhlke S, Biersack HJ. Palmedo H, et al. J Clin Oncol. 2003 Aug 1;21(15):2869-75. doi: 10.1200/JCO.2003.12.060. J Clin Oncol. 2003. PMID: 12885803 Clinical Trial.

8

[Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].

Hauswirth AE, Palmedo H, Dierke-Dzierzon C, Biersack HJ, Krebs D. Hauswirth AE, et al. Among authors: palmedo h. Zentralbl Gynakol. 1998;120(2):83-6. Zentralbl Gynakol. 1998. PMID: 9531713 German.

9

Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.

Schoeneich G, Palmedo H, Dierke-Dzierzon C, Müller SC, Biersack HJ. Schoeneich G, et al. Among authors: palmedo h. Scand J Urol Nephrol. 1997 Oct;31(5):445-8. doi: 10.3109/00365599709030639. Scand J Urol Nephrol. 1997. PMID: 9406304 Clinical Trial.

10

Unilateral iodine-131 uptake in the lactating breast.

Grünwald F, Palmedo H, Biersack HJ. Grünwald F, et al. Among authors: palmedo h. J Nucl Med. 1995 Sep;36(9):1724-5. J Nucl Med. 1995. PMID: 7658239 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page